Kaissy Hammer
Psychiatric/Mental Health · West Monroe, LANPI 1275813834
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,574 and has fallen 62.0% since, to $979 in 2025. Among psychiatric/mental health clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $49.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Neurocrine Biosciences, Inc.$812
- Alkermes, Inc.$784
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$743
- Axsome Therapeutics, Inc.$387
- AstraZeneca$360
- plus $2K from 23 others
What the payments were for
- Food & beverage$6,856100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $1,531 |
| Neurocrine Biosciences, Inc. | 11 | $812 |
| Alkermes, Inc. | 19 | $784 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $743 |
| Axsome Therapeutics, Inc. | 5 | $387 |
| AstraZeneca(2 entities) | 4 | $360 |
| Gilead | 2 | $192 |
| Johnson & Johnson | 3 | $143 |
| Otsuka America Pharmaceutical, Inc. | 2 | $137 |
| Braeburn Inc. | 5 | $128 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Calliditas Therapeutics US Inc. | 1 | $125 |
| Biohaven Pharmaceuticals, Inc. | 1 | $125 |
| Viatris Specialty LLC | 1 | $122 |
| Abbott | 1 | $108 |
| Exact Sciences | 1 | $107 |
| Bayer | 1 | $98 |
| E.r. Squibb & Sons, L.L.C. | 1 | $98 |
| Edwards Lifesciences | 1 | $96 |
| Novo Nordisk | 2 | $93 |
| Neurelis, Inc. | 1 | $87 |
| GSK | 1 | $81 |
| Sage Therapeutics, LLC | 1 | $80 |
| Indivior Inc. | 3 | $75 |
| Viiv Healthcare Company | 1 | $75 |
| Itamar Medical Inc | 1 | $57 |
| Evofem Biosciences, Inc. | 1 | $50 |
| USWM, LLC | 1 | $26 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$630
- LYBALVI$500
- VRAYLAR$470
- CAPLYTA$439
- ARISTADA$423
- Auvelity$250
- NURTEC ODT$125
- ULTOMIRIS$125
- UZEDY$125
- QULIPTA$125
- UBRELVY$125
- TARPEYO$125
- REXULTI$124
- Yupelri$122
- Epclusa$112
- FREESTYLE LIBRE 3$108
- Cologuard Collection Kit$107
- ARISTADA INITIO$106
How this compares
$6,860 in reported general payments places this provider in the 90th percentile of 615 psychiatric/mental health providers in Louisiana.
Other psychiatric/mental health in West Monroe
- Amy LacoutureBaton Rouge$663K
- Amanda EymardHouma$617K
- Amber LittlefieldBroussard$225K
- Timothy PellegrinHouma$210K
- Melissa GuilbeauLafayette$122K
- Kimberly ForcinelShreveport$92K
- Sattaria DilksLake Charles$57K
- Joe TaylorHammond$38K
- Lecy AlbaradoScott$34K
- Michelle DyerLake Charles$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.